Here's this week's company in the spotlight 🔦
Aurobindo Pharma is set to have an estimated EBITDA of ₹76,215 by 2027.
🔗Research report: https://bit.ly/4jNrshJ
🔗Disclaimer: http://ow.ly/63nS50Lqple#Stocksfor2025 #StockMarketIndia #StockMarketInvesting #IndianStockMarket #ShareMarket #ShareMarketIndia #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal #Stocksfor2025 #StockMarketIndia #StockMarketInvesting #IndianStockMarket #ShareMarket #ShareMarketIndia #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal
Posted on : 14 May 2025 8:31 AM